NCT07886593
Diode Laser Added to Non-Surgical Treatment for Peri-Implant Mucositis
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Change From Baseline in Bleeding on Probing (BOP)
Timeframe: Baseline, 4-6 weeks, 3 months, 6 months, and 12 months
Secondary (4)
Change From Baseline in Plaque Index (PI)
Change From Baseline in Probing Depth (PD)
Change From Baseline in Peri-Implant Crevicular Fluid (PICF) Volume
Change From Baseline in Matrix Metalloproteinase-8 (MMP-8) Levels
Arms and interventions
Control GroupActive comparator
Participants received conventional non-surgical treatment for peri-implant mucositis, including mechanical debridement with Teflon curettes and an ultrasonic device with a Teflon tip, irrigation with 0.12% chlorhexidine and 0.05% cetylpyridinium chloride, and individualized oral hygiene instructions.
Diode Laser GroupExperimental
Participants received the same conventional non-surgical treatment as the control group plus adjunctive diode laser therapy using an 810-nm diode laser.
Procedures: Conventional Non-Surgical Treatment
Devices: Adjunctive Diode Laser Therapy
Sites
1 site in 1 country
- Universidad Europea de ValenciaValencia, Valencia, Spain